v3.26.1
SCHEDULE OF BASIC AND DILUTED EARNINGS PER SHARE (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Earnings Per Share [Abstract]        
Net loss from continuing operations $ (7,083,941) $ (3,007,673) $ (15,956,537) $ (4,653,028)
Less: Preferred stock dividends (776,562) (776,562) (1,553,125) (1,553,125)
Net loss from continuing operations attributable to LifeMD, Inc. common stockholders (7,860,503) (3,784,235) (17,509,662) (6,206,153)
Net income from discontinued operations 1,893,084 3,886,506
Less: Net income attributable to noncontrolling interests of discontinued operations 505,075 1,036,920
Net income from discontinued operations attributable to LifeMD, Inc. 1,388,009 2,849,586
Net loss attributable to LifeMD, Inc. common stockholders $ (7,860,503) $ (2,396,226) $ (17,509,662) $ (3,356,567)